DJIA 17,811.10 -3.84 -0.02%
NASDAQ 4,773.50 15.25 0.32%
S&P 500 2,068.89 1.86 0.09%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

88.38 -1.07 (-1.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMRN $88.38 -1.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.55
Previous Close $89.45
Daily Range $88.19 - $89.95
52-Week Range $55.04 - $91.40
Market Cap $13.0B
P/E Ratio -101.65
Dividend (Yield) $0.00 (0.0%)
Volume 284,970
Average Daily Volume 1,204,016
Current FY EPS -$1.06





BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

New Lifetime High Today: Biomarin Pharmaceutical (BMRN)

RBC Has Three Top Biotech Picks for Year End and 2015

Benzinga's M&A Chatter for Monday November 24, 2014

Closing Update: Stocks Extend Winning Streak to Third Day

S&P 500 Little Changed Amid Uncertainty Over U.S. Economic Growth

Barbarian At The Gate: Biomarin Pharmaceutical (BMRN)

Health Care Sector Update for 11/24/2014: TTPH,ATLN,RHHBY,RNA,BMRN,TTHI,TTH.TO

See More BMRN News...

BMRN's Top Competitors

BMRN $88.38 (-1.20%)
Current stock: BMRN
AMGN $163.15 (0.56%)
Current stock: AMGN
GILD $100.53 (-0.57%)
Current stock: GILD
BIIB $302.78 (-0.86%)
Current stock: BIIB